Explore

Trendline Trendline
NeuraLight Biomarkers Outperform Gold-Standard Parkinson's Measurement in New Study

NeuraLight Biomarkers Outperform Gold-Standard Parkinson's Measurement in New Study

NeuraLight Biomarkers Outperform Gold-Standard Parkinson's Measurement in New Study
Rapid Read Rapid Read
Microglia Transitions Identified as Key Factor in Alzheimer's Disease Progression

Microglia Transitions Identified as Key Factor in Alzheimer's Disease Progression

Researchers from VIB, KU Leuven, and Muna Therapeutics have identified critical transitions in microglia, the brain's immune cells, that may determine the progression of Alzheimer's disease to dementia. The study, published in Nature Medicine, analyzed brain tissue from individuals with and without cognitive decline, revealing distinct cellular programs associated with disease progression and resilience. The findings suggest that changes in microglia could be targeted for future Alzheimer's therapies, offering new insights into how some individuals remain cognitively healthy despite Alzheimer's pathology.
Rapid Read Rapid Read
Microglia Transitions Identified as Key in Alzheimer's Disease Progression

Microglia Transitions Identified as Key in Alzheimer's Disease Progression

A study published in Nature Medicine has identified critical transitions in microglia, the brain's immune cells, as pivotal in the progression of Alzheimer's disease. Researchers from VIB, KU Leuven, and other institutions found that changes in microglial states are associated with disease progression and resilience. The study suggests that individuals who remain cognitively healthy despite Alzheimer's pathology do so through distinct biological mechanisms involving microglia. These findings highlight the potential of targeting microglial transitions as a therapeutic strategy for Alzheimer's, offering new avenues for preventing neurodegeneration and dementia.
Rapid Read Rapid Read
Study Links Body Fat Distribution to Accelerated Brain Aging in Adults

Study Links Body Fat Distribution to Accelerated Brain Aging in Adults

A study published in Nature Mental Health has revealed that the distribution of body fat significantly influences brain structure, function, and cognitive performance in middle-aged and older adults. The research, led by Anqi Qiu of The Hong Kong Polytechnic University, analyzed data from over 18,000 UK Biobank participants. It found that visceral fat, which is stored around internal organs, releases inflammatory chemicals linked to neuroinflammation and neurodegeneration. In contrast, limb fat has been considered protective in some contexts. The study used advanced imaging techniques to assess brain health and found that different fat depots are associated with distinct patterns of neurological change. Visceral fat was particularly damaging, showing strong links to deterioration in the brain's white matter.
Trendline Trendline
Neurologist Shares Daily Routines for Longevity and Brain Health

Neurologist Shares Daily Routines for Longevity and Brain Health

Neurologist Shares Daily Routines for Longevity and Brain Health
Rapid Read Rapid Read
MIT and Harvard Researchers Investigate Fever's Impact on Autism Symptoms

MIT and Harvard Researchers Investigate Fever's Impact on Autism Symptoms

Researchers from MIT and Harvard Medical School are exploring the phenomenon where autism symptoms appear to ease during a fever. This 'fever effect' has been observed by parents and caregivers, and the research team, supported by a $2.1 million grant from the Marcus Foundation, aims to understand the underlying biology. Neuroscientist Gloria Choi and immunologist Jun Huh have conducted a decade of research in mice, identifying an immune-signaling molecule, IL-17a, that seems to calm overactive brain circuits during infections. Their findings suggest that the improvement in symptoms is linked to this molecule rather than the fever itself. The team plans to create a biobank of blood and stool samples from volunteers to further investigate these markers in humans.
Rapid Read Rapid Read
Research Highlights Gut Microbiome's Role in Cancer Treatment

Research Highlights Gut Microbiome's Role in Cancer Treatment

Recent research has highlighted the potential role of the gut microbiome in enhancing cancer treatment outcomes. Studies suggest that a healthier gut microbiome may improve the effectiveness of immunotherapy in cancer patients. Researchers are exploring various interventions, including probiotics and dietary changes, to manipulate the gut microbiome and boost immune responses against cancer. This emerging field of study is gaining attention for its potential to revolutionize cancer care by leveraging the body's natural microbiota.
Rapid Read Rapid Read
Study Explores Menopause's Impact on Stroke and Alzheimer's Risk in Women

Study Explores Menopause's Impact on Stroke and Alzheimer's Risk in Women

A recent discussion on Iowa Public Radio's 'River to River' highlights the increased risk of stroke and Alzheimer's disease in women post-menopause. Dr. Hannah Roeder, a neurologist at the University of Iowa, explains that stroke risk nearly doubles for women in the decade following menopause. The program also discusses a new study investigating whether menopause accelerates brain and blood vessel aging, potentially explaining the higher incidence of these conditions in women. Dr. Enrique Leira from the University of Iowa Comprehensive Stroke Center discusses the 'Code Stroke' system, which has improved stroke recognition and response across Iowa for the past 20 years.
Rapid Read Rapid Read
Allen Institute Advances Genetic Therapy for Brain Disorders with New Accelerator

Allen Institute Advances Genetic Therapy for Brain Disorders with New Accelerator

The Allen Institute in Seattle has launched the Brain Health accelerator, a collaborative initiative aimed at developing genetic therapies for brain disorders such as Alzheimer's, Parkinson's, ALS, and Huntington's disease. This effort is part of the broader BRAIN Initiative, a public-private partnership initiated in 2013 to advance brain research and treatment development. The accelerator seeks to translate scientific knowledge about the brain into practical treatments by leveraging genetic therapies, including gene editing. Scientists at the Allen Institute have made significant progress in understanding the genetic underpinnings of brain cells, which is crucial for developing precision therapies. The initiative is attracting researchers like Jeff Carroll, who is focused on Huntington's disease, a condition he has a personal connection to. The accelerator's approach allows for large-scale research efforts that smaller labs cannot achieve alone.
Rapid Read Rapid Read
Neurologist Highlights Hopeful Advances in Stroke and Head Injury Recovery

Neurologist Highlights Hopeful Advances in Stroke and Head Injury Recovery

Orlando Swayne, a consultant neurologist, emphasizes the potential for recovery in patients with severe brain injuries through targeted therapy and neuroplasticity. His work at the National Hospital for Neurology and Neurosurgery focuses on the brain's ability to reorganize and form new connections after a stroke or head injury. Swayne's approach challenges the traditional view that brain injuries are irreversible, advocating for early and intensive therapy to maximize recovery. His insights are detailed in his new book, which argues for the importance of providing adequate rehabilitation to improve patients' quality of life.
Trendline Trendline
Ethan Lawson Commits to West Virginia University with Unique Announcement

Ethan Lawson Commits to West Virginia University with Unique Announcement

Ethan Lawson Commits to West Virginia University with Unique Announcement
Rapid Read Rapid Read
FNIH Honors Dan Doctoroff, Biogen, and NIAMS with 2026 Partnership Award for Biomedical Research Contributions

FNIH Honors Dan Doctoroff, Biogen, and NIAMS with 2026 Partnership Award for Biomedical Research Contributions

The Foundation for the National Institutes of Health (FNIH) has announced the recipients of the 2026 Charles A. Sanders, MD, Partnership Award. The award will be presented to Dan Doctoroff, founder of Target ALS, Biogen, and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This recognition is for their significant contributions to advancing biomedical research in support of the NIH mission. Doctoroff has been instrumental in the Accelerating Medicines Partnership (AMP) Amyotrophic Lateral Sclerosis (ALS) program, which has initiated the ALS Knowledge Portal, a major data source for ALS research. Biogen has been a longstanding partner with FNIH, supporting various initiatives in immunology and neuroscience. NIAMS has played a crucial role in developing the AMP program, which aims to transform the development of new diagnostics and treatments.